OSE Immunotherapeutics SA
PAR:OSE
OSE Immunotherapeutics SA
Other Items
OSE Immunotherapeutics SA
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
OSE Immunotherapeutics SA
PAR:OSE
|
Other Items
-€46.8m
|
CAGR 3-Years
-409%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Valneva SE
PAR:VLA
|
Other Items
€93.4m
|
CAGR 3-Years
1 093%
|
CAGR 5-Years
242%
|
CAGR 10-Years
32%
|
|
|
Nanobiotix SA
PAR:NANO
|
Other Items
-€107k
|
CAGR 3-Years
-128%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
21%
|
|
|
G
|
Genfit SA
PAR:GNFT
|
Other Items
€90k
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Inventiva SA
PAR:IVA
|
Other Items
€9.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eurobio Scientific SA
PAR:ALERS
|
Other Items
€18.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
40%
|
|
OSE Immunotherapeutics SA
Glance View
OSE Immunotherapeutics SA develops immunotherapy products for cancer and auto-immune disease. The company is headquartered in Nantes, Pays De La Loire and currently employs 61 full-time employees. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.
See Also
What is OSE Immunotherapeutics SA's Other Items?
Other Items
-46.8m
EUR
Based on the financial report for Dec 31, 2024, OSE Immunotherapeutics SA's Other Items amounts to -46.8m EUR.
What is OSE Immunotherapeutics SA's Other Items growth rate?
Other Items CAGR 3Y
-409%
Over the last year, the Other Items growth was -16 930%. The average annual Other Items growth rates for OSE Immunotherapeutics SA have been -409% over the past three years .
You don't have any saved screeners yet